The company will permit six generic drugmakers to make and sell lenacapavir in 120 countries that have high incidence of the disease, but limited resources.

Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town A new drug to prevent HIV infection ...

Experts And Viewpoints, October 02, 2006 An Expert Interview With Dr. Cal Cohen Recent approvals of new HIV drugs and a rich ... comparison of commercial phenotypic tests, and more.

New Drug Shows Promise in Clearing HIV from Brain July 25, 2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a ...

Since the FDA approved the drug in 2012, more people have started to use it, and HIV rates have steadily decreased. However, not everyone sees the same results. The South had 53% of new HIV ...

It is a combination of oral PrEP for HIV prevention and oral contraception. As both drugs are approved, the new combination has to be proven to show its efficacy. The pill, made by Viatris ...

It is good news for millions of Kenyans living with HIV/AIDS as Kenya will start buying new highly-effective antiretroviral drugs at much lower prizes following an international price deal.

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a brand-name tablet prescribed for HIV-1. As with other drugs, Biktarvy can cause side effects, such as ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

People with HIV are more likely to have severe premenstrual syndrome (PMS) symptoms than others, such as: In the United States, about 2% of transgender people make up new HIV diagnoses.

HIV most commonly spreads during unprotected sex (sex without a condom or in the absence of a medication to prevent or treat HIV) or through sharing injection drug equipment like needles.

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease ...